Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
Tortoli, E., Rindi, L., Goh, K. S., Katila, M. L., Mariottini, A., Mattei, R., Mazzarelli, G., Suomalainen, S., Torkko, P., & Rastogi, N. (2005). Mycobacterium florentinum sp. nov., isolated from humans. International Journal of Systematic and Evolutionary Microbiology, 55(Pt 3), 1101–1106.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and clinical sources (sputum)
DNA G+C(%): 66.4
|
Lower T(℃): 25(+)
Mid T(℃): 37(+)
High T(℃): 45(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
|
|
amikacin: RNG: (0.5-4)
|
clarithromycin: SensRNG: (2-2)
|
ciprofloxacin: R(4-128)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
rifabutin: SensRNG: (0.06-0.25)
rifampicin: R(4-16)
|
|
|